Depakote ER Therapy for Mania Comorbid With Substance Abuse
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to ascertain whether Depakote ER (Divalproex ER) has efficacy in
the treatment of patients with bipolar disorder in the manic phase, who also have comorbid
substance abuse diagnoses. It is proposed that Depakote ER will decrease scores on the Young
Mania Rating Scale and the Substance Abuse Time Line Follow Back.